Karine Reybier

Prof. Dr. Karine Reybier


Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2003 in Materials Science and Engineering: C
Verified
Journal Article
Closed access
LPL. Ponsonnet
L. Ponsonnet
KRKarine Reybier
Karine Reybier
NJN. Jaffrezic
N. Jaffrezic
VCV. Comte
V. Comte
CLC. Lagneau
C. Lagneau
CMC. Martelet
C. Martelet

5 March 2008 in Malaria Journal
Verified
Journal Article
Open access
PDF file
CRClotilde Ribaut
Clotilde Ribaut
ABAntoine Berry
Antoine Berry
SCSéverine Chevalley
Séverine Chevalley
KRKarine Reybier
Karine Reybier
IMIsabelle Morlais
Isabelle Morlais
AVAlexis Valentin
Alexis Valentin
Background: Parasite concentration methods facilitate molecular, biochemical and immunological research on the erythrocytic stages of Plasmodium. In this paper, an adaptation of magnetic MACS® columns for the purification of human Plasmodium species is presented. This method was useful for the concentration/purification of either schizonts or gametocytes. Results and conclusions: The magnetic removal of non-parasitized red blood cells (in vivo and in vitro) using magnetic columns (MACS) was evaluated. This easy-to-use technique enriched schizonts and gametocytes from Plasmodium falciparum in vitro cultures with a very high degree of purity. In addition, all haemozoin-containing stages (schizonts and/or gametocytes) from the peripheral blood of infected patients could be concentrated using this method. This method is particularly useful for the concentration of non-falciparum species, which do not grow in culture and are otherwise difficult to obtain in large amounts.

2 December 2015 in Angewandte Chemie International Edition
Verified
Journal Article
Closed access
PDF file
KRKarine Reybier
Karine Reybier
SASara Ayala
Sara Ayala
BBBruno Bruno
Bruno Bruno
JRJoão V. Rodrigues
João V. Rodrigues
SRSusana Bustos Rodriguez
Susana Bustos Rodriguez
Peter FallerPeter Faller
Peter Faller

15 July 2011 in Free Radical Research
Verified
Journal Article
Closed access
PDF file
KRKarine Reybier
Karine Reybier
PPPierre PERIO
Pierre PERIO
GFGilles Ferry
Gilles Ferry
Jalloul BouajilaJalloul Bouajila
Jalloul Bouajila
PDPhilippe Delagrange
Philippe Delagrange
FNFrançoise Nepveu
Françoise Nepveu
NRH:quinone oxidoreductase 2 (QR2) is a cytosolic enzyme that catalyzes the reduction of quinones, such as menadione and co-enzymes Q. With the aim of understanding better the mechanisms of action of QR2, we approached this enzyme catalysis via electron paramagnetic resonance (EPR) measurements of the by-products of the QR2 redox cycle. The variation in the production of oxidative species such as H2O2, and subsequent hydroxyl radical generation, was measured during the course of QR2 activity under aerobic conditions and using pure human enzyme. The effects on the activity of the following were compared: (i) synthetic (N-benzyldihydronicotinamide, BNAH) or natural (nicotinamide riboside, NRH) co-substrates; (ii) synthetic (menadione) or natural (co-enzyme Q0, Q2) substrates; (iii) QR2 modulators and inhibitors (melatonin, resveratrol and S29434); (iv) a pro-drug activated via a redox cycle [CB1954, 5-(aziridin-1-yl)-2,4-dinitrobenzamide]. The results were also compared with those obtained with human QR1. The production of hydroxyl radicals is: (i) observed whatever the substrate/co-substrate used; ii) quenched by adding catalase; (iii) not observed with the specific QR2 inhibitor S29434; (iv) observed with the pro-drug CB1954. While QR2 produced free radicals with this pro-drug, QR1 gave no EPR signal showing the strong reducing capacity of QR2. In conclusion, EPR analysis of QR2 enzyme activity through free radical production enables modulators and effective inhibitors to be distinguished.

1 February 2022 in Free Radical Biology and Medicine
Verified
Journal Article
Open access
CEChinedu Ogbonnia Egwu
Chinedu Ogbonnia Egwu
PPPierre PERIO
Pierre PERIO
JAJean-Michel Augereau
Jean-Michel Augereau
Ioannis TsamesidisIoannis Tsamesidis
Ioannis Tsamesidis
FBFrançoise Benoit-Vical
Françoise Benoit-Vical
KRKarine Reybier
Karine Reybier
Malaria remains a major public health disease due to its high yearly mortality and morbidity. Resistance to the gold standard drug, artemisinin, is worrisome and needs better understanding in order to be overcome. In this work, we sought to study whether redox processes are involved in artemisinin resistance. As artemisinin is known to act among others via production of reactive species, we first compared the production of reactive oxygen species and concomitant protein oxidation in artemisinin-sensitive and artemisinin-resistant parasites when treated with artemisinin. The results undoubtedly demonstrated, using different original methods, that the level of ROS, including superoxide production, and oxidized protein were lower in the resistant strain. Interestingly, the major in-between strain difference was reported at the earlier ring stages, which are the forms able to enter in a quiescence state according to the ART resistance phenomenon. Moreover, we demonstrated a better homeostasis regulation in relation with higher expression of antioxidants in the artemisinin-resistant parasites than their sensitive counterparts after artemisinin exposure, notably, superoxide dismutase and the glutathione (GSH) system. These findings enrich the body of knowledges about the multifaceted mechanism of artemisinin resistance and will help in the design and development of newer antimalarials strategies active against resistant parasites.

1 August 2002 in Analytica Chimica Acta
Verified
Journal Article
Open access
MHM.L Hamlaoui
M.L Hamlaoui
KRKarine Reybier
Karine Reybier
MMM Marrakchi
M Marrakchi
NJN Jaffrezic-Renault
N Jaffrezic-Renault
CMC Martelet
C Martelet
AWA Walcarius
A Walcarius